Tetrazepam

CAS 10379-14-3 1 current recordSmall Molecule

Who holds supplier records for Tetrazepam? 1 organisation holds a current record for Tetrazepam: an active US FDA Type II Drug Master File or a CEP. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: France (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Tetrazepam: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/tetrazepam

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tetrazepam. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CENTIPHARM Grasse
    Valid CEP holder (EDQM); not necessarily the manufacturer
    FranceCEP
Need Tetrazepam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Tetrazepam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CENTIPHARM GrasseFR
R1-CEP 2007-003 - Rev 00
Tetrazepam
Jan 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Overview

Tetrazepam is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2105527).

Chemical identity

IUPAC name
7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one
Canonical SMILES
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CCCCC3
InChIKey
IQWYAQCHYZHJOS-UHFFFAOYSA-N
Synonyms
CB 4261, CB-4261, Myolastan, Tetrazepam, Musaril, Clinoxan, RefChem:188914, Ro 06-6657, 4261 CB, Tetrazepam (INN), TETRAZEPAM [INN], Tetrazepam (1mg/ml in Methanol)

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tetrazepam?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Tetrazepam: CENTIPHARM Grasse (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Does Tetrazepam have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Tetrazepam on the EDQM register, including CENTIPHARM Grasse (FR). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tetrazepam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tetrazepam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.